Novavax Inks Covid-19 Vaccine Deal With U.K. for 60 Million Doses

Novavax Inc. has agreed to provide 60 million doses of its coronavirus vaccine to the U.K. for an undisclosed sum, as countries move to secure supplies of the shots.

Under the terms, the U.K. will fund a late-stage trial of Novavax’s vaccine candidate starting this quarter evaluating the shot in the country’s residents, and a contract...